| Literature DB >> 27400265 |
Dongryeol Ryu1, Laurent Mouchiroud1, Pénélope A Andreux1,2, Elena Katsyuba1, Norman Moullan1, Amandine A Nicolet-Dit-Félix1, Evan G Williams1, Pooja Jha1, Giuseppe Lo Sasso1, Damien Huzard3, Patrick Aebischer4, Carmen Sandi3, Chris Rinsch2, Johan Auwerx1.
Abstract
The biological effects of urolithins remain poorly characterized, despite wide-spread human exposure via the dietary consumption of their metabolic precursors, the ellagitannins, which are found in the pomegranate fruit, as well as in nuts and berries. We identified urolithin A (UA) as a first-in-class natural compound that induces mitophagy both in vitro and in vivo following oral consumption. In C. elegans, UA prevented the accumulation of dysfunctional mitochondria with age and extended lifespan. Likewise, UA prolonged normal activity during aging in C. elegans, including mobility and pharyngeal pumping, while maintaining mitochondrial respiratory capacity. These effects translated to rodents, where UA improved exercise capacity in two different mouse models of age-related decline of muscle function, as well as in young rats. Our findings highlight the health benefits of urolithin A and its potential application in strategies to improve mitochondrial and muscle function.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27400265 DOI: 10.1038/nm.4132
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440